Shield Therapeutics
Latest round
- Series A
Last raised
- Jun 2011
Total raised
- $12M
Investors
- 1
About Shield Therapeutics
Founded in 2008 and headquartered in Newcastle, UK, Shield Therapeutics specializes in specialty pharmaceuticals for iron deficiency.5 million. The founder, Christian Schweiger, has a background in pharmaceuticals, and the current leadership includes CEO Greg Madison.Shield Therapeutics plc specializes in developing innovative specialty pharmaceuticals aimed at addressing significant unmet medical needs related to iron deficiency. Their flagship product, ACCRUFeR® (ferric maltol), is a stable, non-salt based oral therapy approved for the treatment of iron deficiency with or without anemia in adults. This product functions by providing a well-tolerated and effective oral iron replacement option, crucial for patients facing challenges with existing therapies. ACCRUFeR® is available in multiple geographical markets including the United States, the European Union, the United Kingdom, and Switzerland.44 million. The company generates revenue primarily through the sales of ACCRUFeR®, focusing on direct transactions with healthcare providers and hospitals, leveraging negotiated contracts that may involve bulk purchasing agreements with healthcare institutions. The company is focused on expanding its product offerings and plans to enter new geographic markets, specifically targeting regions that require effective iron deficiency treatments.
Who invested in Shield Therapeutics
1 investor across 1 round
See all investors in Shield Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Jun 1, 2011
Amount
$12M
Investors
Questions about Shield Therapeutics
Who invested in Shield Therapeutics?
Shield Therapeutics has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Shield Therapeutics raised?
Shield Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Shield Therapeutics last raise money?
Shield Therapeutics's most recent round on record is a Series A, in Jun 2011.
What does Shield Therapeutics do?
Founded in 2008 and headquartered in Newcastle, UK, Shield Therapeutics specializes in specialty pharmaceuticals for iron deficiency.
Where is Shield Therapeutics headquartered?
Shield Therapeutics is headquartered in Newcastle, UK.
Which VCs invest in companies like Shield Therapeutics?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back pharmaceuticals companies at Shield Therapeutics's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like Shield Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.